Name: Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade
SKU: PX-TA1172
Availability: InStock

Free sample request
Secured Payment Methods
Engaged for the Environment

Size	100ug, 1MG
Isotype	IgG1, kappa
Brand	ProteoGenix
Product type	Primary Antibodies
Clonality	Monoclonal Antibody
Expression system	Mammalian cells
Applications	Elisa, WB

Signal Transduction Primary Antibodies ELISA WB Therapeutic Antibodies

Product name	Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade
Source	CAS 949142-50-1
Species	Humanized
Molecular weight	150kDa
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery lead time in business days	3-5 days if in stock; 3-5 weeks if production needed
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Aliases /Synonyms	Obinutuzumab,GA101,RG7159,RO5072759,afutuzumab,MS4A1, CD20,anti-MS4A1, CD20
Reference	PX-TA1172
Note	For research use only. Not suitable for human use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

Description of Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade

General information on Anti-MS4A1/CD20(Homo sapiens) (Obinutuzumab) Monoclonal Antibody

Obinutuzumab is a humanized monoclonal antibody that can be used in combination with chlorambucil to treat chronic lymphocytic leukemia. It was sold under the Gazyva brand. There are black box warnings of fatal hepatitis B virus (HBV) reactivation and fatal progressive multifocal leukoencephalopathy (PML).

Datasheet Download

MSDS Download

Publication

Joshua S. Bray, Gethin R. Thomas, Victoria M. Smith, Sandrine Jayne, Martin J.S. Dyer, Harriet S. Walter, Comparative in-Vitro Efficacy of CD20xCD3 IgG Bispecific Biosimilar Constructs Against Diffuse Large B Cell Lymphoma (DLBCL) Cell Lines with Different Levels of Expression of CD20, Blood, Volume 144, Supplement 1, 2024, Page 5826, ISSN 0006-4971, https://doi.org/10.1182/blood-2024-203884.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Obinutuzumab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Price and Availability

Size

Clear

GET A QUOTE NOW

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us

CD20 Protein – Human CD20 Recombinant Protein

PX-P3060 250$

View product

Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 215$

View product

Polyclonal Antibody

Anti-Obinutuzumab Polyclonal Antibody

PTX18871 774$

View product

ELISA

Obinutuzumab ELISA Kit

KPTX173 1404$

View product

Contact us

Send us a message from the form below

Obinutuzumab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade

Description of Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade

General information on Anti-MS4A1/CD20(Homo sapiens) (Obinutuzumab) Monoclonal Antibody

REVIEW YOUR PRODUCT

CD20 Protein – Human CD20 Recombinant Protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Anti-Obinutuzumab Polyclonal Antibody

Obinutuzumab ELISA Kit

Contact us

Cart (0 Items)